• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clostridium difficile ribotype does not predict severe infection.艰难梭菌核糖体分型不能预测严重感染。
Clin Infect Dis. 2012 Dec;55(12):1661-8. doi: 10.1093/cid/cis786. Epub 2012 Sep 12.
2
ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study.2004 年至 2018 年,ribotypes 001 和 126 在德黑兰医疗保健环境中占主导地位:一项长达 14 年的横断面研究。
Emerg Microbes Infect. 2020 Dec;9(1):1432-1443. doi: 10.1080/22221751.2020.1780949.
3
Clostridium difficile infection in an Iranian hospital.伊朗一家医院的艰难梭菌感染
BMC Res Notes. 2012 Mar 21;5:159. doi: 10.1186/1756-0500-5-159.
4
An Observational Cohort Study of Ribotype 027 and Recurrent Infection.027 型与再感染的观察性队列研究。
mSphere. 2018 May 23;3(3). doi: 10.1128/mSphere.00033-18. eCollection 2018 May-Jun.
5
Ribotyping of Clostridium difficile strains associated with nosocomial transmission and relapses in a Swedish County.与瑞典县内医院感染传播和复发相关的艰难梭菌菌株的核糖体分型。
APMIS. 2013 Feb;121(2):153-7. doi: 10.1111/j.1600-0463.2012.02950.x. Epub 2012 Jul 25.
6
In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent.在地方病环境中,艰难梭菌核糖体分型027具有致病性,但并非高致病性。
Infect Control Hosp Epidemiol. 2015 Nov;36(11):1318-23. doi: 10.1017/ice.2015.187. Epub 2015 Aug 20.
7
Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018.意大利对氟喹诺酮类药物具有抗药性的艰难梭菌分离株:出现 PCR 核糖型 018。
J Clin Microbiol. 2010 Aug;48(8):2892-6. doi: 10.1128/JCM.02482-09. Epub 2010 Jun 16.
8
Emergence of Clostridium difficile ribotype 027 in Korea.韩国艰难梭菌核糖型027的出现。
Korean J Lab Med. 2011 Jul;31(3):191-6. doi: 10.3343/kjlm.2011.31.3.191. Epub 2011 Jun 28.
9
Clostridium difficile ribotype 027: relationship to age, detectability of toxins A or B in stool with rapid testing, severe infection, and mortality.艰难梭菌核糖体分型027:与年龄的关系、粪便中毒素A或B快速检测的可检测性、严重感染及死亡率
Clin Infect Dis. 2015 Jul 15;61(2):233-41. doi: 10.1093/cid/civ254. Epub 2015 Mar 31.
10
Detection of mixed populations of Clostridium difficile from symptomatic patients using capillary-based polymerase chain reaction ribotyping.应用基于毛细管的聚合酶链反应核糖体分型技术检测有症状患者中艰难梭菌的混合种群。
Infect Control Hosp Epidemiol. 2013 Sep;34(9):961-966. doi: 10.1086/671728. Epub 2013 Jul 12.

引用本文的文献

1
Epidemiology and genetic characteristics of isolates in Northwest China.中国西北地区分离株的流行病学和遗传特征
PeerJ. 2025 Aug 15;13:e19877. doi: 10.7717/peerj.19877. eCollection 2025.
2
Genomic and phenotypic studies among isolates show a high prevalence of clade 2 and great diversity in clinical isolates from Mexican adults and children with healthcare-associated diarrhea.对 株进行的基因组和表型研究表明,来自墨西哥与医疗保健相关腹泻的成人和儿童临床分离株中,2 型分支的流行率很高,且具有很大的多样性。
Microbiol Spectr. 2024 Jul 2;12(7):e0394723. doi: 10.1128/spectrum.03947-23. Epub 2024 Jun 12.
3
": The Epidemiology of Toxigenic Strains in the Antibiotic Era-Insights from a Prospective Study at a Regional Infectious Diseases Hospital in Eastern Europe.:抗生素时代产毒菌株的流行病学——来自东欧一家地区传染病医院前瞻性研究的见解。
Antibiotics (Basel). 2024 May 17;13(5):461. doi: 10.3390/antibiotics13050461.
4
Genomic surveillance of transmission and virulence in a healthcare setting.医疗机构中传播与毒力的基因组监测。
mBio. 2024 Mar 13;15(3):e0330023. doi: 10.1128/mbio.03300-23. Epub 2024 Feb 8.
5
Molecular epidemiological analyses of isolates in a university hospital in Japan.日本一家大学医院分离株的分子流行病学分析。
Heliyon. 2023 Sep 16;9(10):e20167. doi: 10.1016/j.heliyon.2023.e20167. eCollection 2023 Oct.
6
Virulence and genomic diversity among clinical isolates of ST1 (BI/NAP1/027) Clostridioides difficile.ST1(BI/NAP1/027)艰难梭菌临床分离株的毒力和基因组多样性。
Cell Rep. 2023 Aug 29;42(8):112861. doi: 10.1016/j.celrep.2023.112861. Epub 2023 Jul 30.
7
Insights into the Evolving Epidemiology of Infection and Treatment: A Global Perspective.《感染与治疗的演变流行病学洞察:全球视角》
Antibiotics (Basel). 2023 Jul 1;12(7):1141. doi: 10.3390/antibiotics12071141.
8
Virulence and genomic diversity among clinical isolates of ST1 (BI/NAP1/027) .ST1(BI/NAP1/027)临床分离株的毒力和基因组多样性
bioRxiv. 2023 Jan 12:2023.01.12.523823. doi: 10.1101/2023.01.12.523823.
9
Comparison of clinical severity, genotype and toxin gene expression of binary toxin-producing clinical isolates in Japan.日本产二元毒素临床分离株的临床严重程度、基因型及毒素基因表达比较
Access Microbiol. 2022 Oct 20;4(10):acmi000362. doi: 10.1099/acmi.0.000362. eCollection 2022.
10
The Gut Bacterial Community Potentiates Clostridioides difficile Infection Severity.肠道细菌群落增强艰难梭菌感染的严重程度。
mBio. 2022 Aug 30;13(4):e0118322. doi: 10.1128/mbio.01183-22. Epub 2022 Jul 20.

本文引用的文献

1
The epidemiology of community-acquired Clostridium difficile infection: a population-based study.社区获得性艰难梭菌感染的流行病学:一项基于人群的研究。
Am J Gastroenterol. 2012 Jan;107(1):89-95. doi: 10.1038/ajg.2011.398. Epub 2011 Nov 22.
2
Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.在非NAP1/BI/027环境下艰难梭菌感染中,结局与治疗持续时间及微生物药敏数据之间缺乏相关性。
Scand J Infect Dis. 2012 Apr;44(4):243-9. doi: 10.3109/00365548.2011.631029. Epub 2011 Nov 13.
3
Co-morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score.合并症是艰难梭菌感染患者死亡的预测因子,并由此得出 ARC 预测评分。
J Hosp Infect. 2011 Dec;79(4):359-63. doi: 10.1016/j.jhin.2011.08.015. Epub 2011 Nov 1.
4
Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes.艰难梭菌感染的临床结果、菌株类型与毒力相关表型之间缺乏关联。
J Clin Microbiol. 2011 Dec;49(12):4040-6. doi: 10.1128/JCM.05053-11. Epub 2011 Sep 28.
5
Binary toxin and death after Clostridium difficile infection.艰难梭菌感染后的二元毒素和死亡。
Emerg Infect Dis. 2011 Jun;17(6):976-82. doi: 10.3201/eid/1706.101483.
6
Non-toxigenic Clostridium sordellii: clinical and microbiological features of a case of cholangitis-associated bacteremia.无细胞毒素梭状芽胞杆菌:与胆管炎相关的菌血症病例的临床和微生物学特征。
Anaerobe. 2011 Oct;17(5):252-6. doi: 10.1016/j.anaerobe.2011.06.009. Epub 2011 Jun 25.
7
MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.MEGA5:用于最大似然法、进化距离法和最大简约法的分子进化遗传学分析。
Mol Biol Evol. 2011 Oct;28(10):2731-9. doi: 10.1093/molbev/msr121. Epub 2011 May 4.
8
Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile.产毒株艰难梭菌 tcdC 型与二元毒素状态与疾病严重程度和结局无关。
J Infect. 2011 May;62(5):355-62. doi: 10.1016/j.jinf.2011.03.001. Epub 2011 Mar 21.
9
Multicenter study of Clostridium difficile infection rates from 2000 to 2006.多中心研究艰难梭菌感染率 2000 年至 2006 年。
Infect Control Hosp Epidemiol. 2010 Oct;31(10):1030-7. doi: 10.1086/656245.
10
Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production.人源强毒力艰难梭菌表现出更高的孢子形成能力和旺盛的毒素产生。
J Bacteriol. 2010 Oct;192(19):4904-11. doi: 10.1128/JB.00445-10. Epub 2010 Jul 30.

艰难梭菌核糖体分型不能预测严重感染。

Clostridium difficile ribotype does not predict severe infection.

机构信息

Department of Internal Medicine, University of Michigan Health System, Ann Arbor, Michigan, USA.

出版信息

Clin Infect Dis. 2012 Dec;55(12):1661-8. doi: 10.1093/cid/cis786. Epub 2012 Sep 12.

DOI:10.1093/cid/cis786
PMID:22972866
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3501335/
Abstract

BACKGROUND

Studies of Clostridium difficile outbreaks suggested that certain ribotypes (eg, 027 and 078) cause more severe disease than other ribotypes. A growing number of studies challenge the validity of this hypothesis.

METHODS

We conducted a cross-sectional study of C. difficile infection (CDI) to test whether ribotype predicted clinical severity when adjusted for the influence of other predictors. Toxigenic C. difficile isolates were cultured from stool samples, screened for genes encoding virulence factors by polymerase chain reaction (PCR) and ribotyped using high-throughput, fluorescent PCR ribotyping. We collected data for 15 covariates (microbiologic, epidemiologic, and laboratory variables) and determined their individual and cumulative influence on the association between C. difficile ribotype and severe disease. We then validated this influence using an independent data set.

RESULTS

A total of 34 severe CDI cases were identified among 310 independent cases of disease (11.0%). Eleven covariates, including C. difficile ribotype, were significant predictors of severe CDI in unadjusted analysis. However, the association between ribotypes 027 and 078 and severe CDI was not significant after adjustment for any of the other covariates. After full adjustment, severe cases were significantly predicted only by patients' white blood cell count and albumin level. This result was supported by analysis of a validation data set containing 433 independent CDI cases (45 severe cases; 10.4%).

CONCLUSIONS

Ribotype is not a significant predictor of severe CDI when adjusted for the influence of any other variables separately or in combination. White blood cell count and albumin level are the most clinically relevant predictors of severe CDI cases.

摘要

背景

艰难梭菌爆发的研究表明,某些核糖体分型(例如 027 和 078)比其他核糖体分型引起更严重的疾病。越来越多的研究对这一假设的有效性提出了质疑。

方法

我们进行了一项艰难梭菌感染(CDI)的横断面研究,以检验在调整其他预测因素的影响后,核糖体分型是否预测临床严重程度。从粪便样本中培养产毒艰难梭菌分离株,通过聚合酶链反应(PCR)筛选编码毒力因子的基因,并使用高通量、荧光 PCR 核糖体分型对其进行分型。我们收集了 15 个协变量(微生物学、流行病学和实验室变量)的数据,并确定了它们对艰难梭菌核糖体分型与严重疾病之间关联的单独和累积影响。然后,我们使用独立数据集验证了这种影响。

结果

在 310 例独立疾病病例中,共确定了 34 例严重 CDI 病例(11.0%)。在未调整分析中,11 个协变量,包括艰难梭菌核糖体分型,是严重 CDI 的显著预测因子。然而,在调整任何其他协变量后,027 和 078 型与严重 CDI 的关联并不显著。在完全调整后,严重病例仅由患者的白细胞计数和白蛋白水平显著预测。这一结果得到了包含 433 例独立 CDI 病例(45 例严重病例;10.4%)的验证数据集分析的支持。

结论

在分别或联合调整其他任何变量的影响后,核糖体分型不是严重 CDI 的显著预测因子。白细胞计数和白蛋白水平是严重 CDI 病例最具临床相关性的预测因子。